Skip to main content
AT

Amide Technologies

Amide Technologies specializes in on-demand peptide synthesis using advanced techniques that combine solid phase peptide synthesis with biological expression, enabling the production of complex peptides and polyamides up to 120 amino acids long. The company addresses the challenge of sourcing hard-to-obtain peptides, providing rapid turnaround times of four days and a delivery rate exceeding 99%, which accelerates drug discovery processes.

Cambridge, United KingdomFounded 201611700+ followers
Updated 20 months ago

Funding

$16.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

TE
Funding rounds are not available yet.

Founders

Product

Problem

Sourcing complex peptides and polyamides, especially those with unnatural amino acids or requiring synthesis beyond typical solid-phase methods, presents a significant bottleneck in drug discovery and materials science. Traditional peptide synthesis methods often struggle with long sequences, modified amino acids, and branched structures, limiting the exploration of novel therapeutic modalities.

Solution

Amide Technologies offers on-demand synthesis of complex peptides and polyamides, bridging the gap between traditional solid-phase peptide synthesis and biological expression. Their platform enables the production of peptides up to 120 amino acids long, incorporating unnatural amino acids and artificial protein backbones to expand the possibilities for novel therapeutic development. By providing rapid turnaround times and high delivery rates, Amide Technologies accelerates design-build-test cycles, empowering researchers to explore a wider range of compounds and therapeutic targets.

Target Audience

Amide Technologies serves researchers and drug discovery companies seeking a reliable source for complex and hard-to-obtain peptides, enabling them to accelerate their research and development efforts.

Features

  • Reliable linear synthesis of polyamides up to 120 amino acids
  • Capability to incorporate unnatural amino acids and create artificial protein backbones
  • High-speed delivery, with urgent orders shipped in less than a week
  • Synthesis of complex structures, including mirror image proteins and branched structures
  • Technology that bridges the gap between traditional solid phase peptide synthesis and biological expression
This profile is AI-generated and may contain inaccuracies.